🔗 Share this article

This year's Nobel Prize in medical science has been granted for transformative discoveries that illuminate how the body's defense network targets harmful infections while protecting the healthy tissues.

Three renowned scientists—from Japan Shimon Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—received this accolade.

The research uncovered specialized "sentinels" within the defense system that eliminate malfunctioning defense cells capable of attacking the organism.

These findings are now paving the way for innovative therapies for autoimmune diseases and malignancies.

The laureates will share a monetary award worth 11m SEK.

Crucial Findings

"Their work has been essential for comprehending how the immune system functions and the reason we don't all suffer from severe self-attack conditions," commented the chair of the Nobel Committee.

This team's studies address a fundamental question: How does the defense system protect us from countless invaders while leaving our healthy cells unharmed?

Our immune system uses immune cells that scan for indicators of disease, even pathogens and bacteria it has not met before.

These cells utilize sensors—called receptors—that are generated randomly in countless combinations.

That provides the immune system the capacity to fight a wide array of invaders, but the randomness of the mechanism unavoidably creates white blood cells that can attack the host.

Protectors of the Immune System

Researchers previously knew that a portion of these problematic white blood cells were destroyed in the thymus—where immune cells develop.

The latest Nobel Prize honors the discovery of T-reg cells—known as the body's "security guards"—which patrol the body to neutralize any defenders that assault the body's own tissues.

We know that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel stated, "The discoveries have laid the foundation for a novel area of research and spurred the creation of innovative treatments, for example for cancer and immune disorders."

In cancer, T-regs block the body from attacking the tumor, so research are aimed at lowering their numbers.

In self-attack disorders, experiments are testing increasing regulatory T-cells so the body is not under attack. A comparable method could also be useful in minimizing the risks of organ transplant rejection.

Innovative Experiments

Prof Shimon Sakaguchi, from Osaka University, conducted experiments on mice that had their immune gland removed, leading to autoimmune disease.

He demonstrated that introducing defense cells from healthy animals could prevent the disease—implying there was a mechanism for preventing defenders from attacking the host.

Dr. Brunkow, from the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an genetic autoimmune disease in rodents and people that resulted in the discovery of a genetic factor vital for how T-regs operate.

"The pioneering research has revealed how the immune system is kept in check by regulatory T cells, stopping it from accidentally attacking the body's own tissues," commented a leading physiology specialist.

"The work is a striking example of how fundamental physiological research can have broad implications for public health."